FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019156783> ?p ?o ?g. }

• W2019156783 endingPage "299" @default.
• W2019156783 startingPage "289" @default.
• W2019156783 abstract "This article reviews the importance of the renin–angiotensin–aldosterone system (RAAS) in the cardiometabolic continuum; presents the pros and cons of dual RAAS blockade with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs); and examines the theoretical and practical benefits supporting the use of direct renin inhibitors (DRIs) in combination with ACEIs or ARBs. The author reviewed the literature for key publications related to the biochemical physiology of the RAAS and the pharmacodynamic effects of ACEIs, ARBs, and DRIs, with a particular focus on dual RAAS blockade with these drug classes. Although ACEI/ARB combination therapy produces modest improvement in BP, it has not resulted in the major improvements predicted given the importance of the RAAS across the cardiorenal disease continuum. This may reflect the fact that RAAS blockade with ACEIs and/or ARBs leads to exacerbated renin release through loss of negative-feedback inhibition, as well as ACE/aldosterone escape through RAAS and non-RAAS-mediated mechanisms. Plasma renin activity (PRA) is an independent predictor of morbidity and mortality, even for patients receiving ACEIs and ARBs. When used alone or in combination with ACEIs and ARBs, the DRI aliskiren effectively reduces PRA. Reductions in BP are greater with these combinations, relative to the individual components alone. It is possible that aliskiren plus either an ACEI or ARB may provide greater RAAS blockade than monotherapy with ACEIs or ARBs, and lead to additive improvement in BP and clinically important outcomes." @default.
• W2019156783 created "2016-06-24" @default.
• W2019156783 creator A5088391372 @default.
• W2019156783 date "2010-02-01" @default.
• W2019156783 modified "2023-09-23" @default.
• W2019156783 title "Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin–angiotensin–aldosterone system: Antihypertensive effects and benefits beyond BP control" @default.
• W2019156783 cites W1963707288 @default.
• W2019156783 cites W1965937466 @default.
• W2019156783 cites W1970068637 @default.
• W2019156783 cites W1974174019 @default.
• W2019156783 cites W1987131398 @default.
• W2019156783 cites W1989963306 @default.
• W2019156783 cites W1994079702 @default.
• W2019156783 cites W1994199177 @default.
• W2019156783 cites W1996325127 @default.
• W2019156783 cites W1999107098 @default.
• W2019156783 cites W2001722069 @default.
• W2019156783 cites W2004840558 @default.
• W2019156783 cites W2004857031 @default.
• W2019156783 cites W2005951646 @default.
• W2019156783 cites W2007836497 @default.
• W2019156783 cites W2010912810 @default.
• W2019156783 cites W2013183546 @default.
• W2019156783 cites W2019019126 @default.
• W2019156783 cites W2019305601 @default.
• W2019156783 cites W2020860227 @default.
• W2019156783 cites W2025672718 @default.
• W2019156783 cites W2026021204 @default.
• W2019156783 cites W2026881482 @default.
• W2019156783 cites W2027381170 @default.
• W2019156783 cites W2027617419 @default.
• W2019156783 cites W2028521865 @default.
• W2019156783 cites W2032576629 @default.
• W2019156783 cites W2034146561 @default.
• W2019156783 cites W2035801283 @default.
• W2019156783 cites W2037521161 @default.
• W2019156783 cites W2040583218 @default.
• W2019156783 cites W2042663838 @default.
• W2019156783 cites W2044815620 @default.
• W2019156783 cites W2045386796 @default.
• W2019156783 cites W2045615482 @default.
• W2019156783 cites W2051035046 @default.
• W2019156783 cites W2056853966 @default.
• W2019156783 cites W2063358281 @default.
• W2019156783 cites W2064508323 @default.
• W2019156783 cites W2067519483 @default.
• W2019156783 cites W2072348500 @default.
• W2019156783 cites W2074022279 @default.
• W2019156783 cites W2074101390 @default.
• W2019156783 cites W2075678264 @default.
• W2019156783 cites W2076217413 @default.
• W2019156783 cites W2078662350 @default.
• W2019156783 cites W2079169944 @default.
• W2019156783 cites W2083444947 @default.
• W2019156783 cites W2085927807 @default.
• W2019156783 cites W2088673227 @default.
• W2019156783 cites W2090763485 @default.
• W2019156783 cites W2092807785 @default.
• W2019156783 cites W2096583106 @default.
• W2019156783 cites W2098312479 @default.
• W2019156783 cites W2098780362 @default.
• W2019156783 cites W2099443408 @default.
• W2019156783 cites W2100409734 @default.
• W2019156783 cites W2106982105 @default.
• W2019156783 cites W2107914594 @default.
• W2019156783 cites W2109366196 @default.
• W2019156783 cites W2110062302 @default.
• W2019156783 cites W2111732405 @default.
• W2019156783 cites W2115309500 @default.
• W2019156783 cites W2118772456 @default.
• W2019156783 cites W2118795360 @default.
• W2019156783 cites W2119642994 @default.
• W2019156783 cites W2121754021 @default.
• W2019156783 cites W2124663880 @default.
• W2019156783 cites W2125086507 @default.
• W2019156783 cites W2125943457 @default.
• W2019156783 cites W2128343930 @default.
• W2019156783 cites W2128451215 @default.
• W2019156783 cites W2128957326 @default.
• W2019156783 cites W2131170531 @default.
• W2019156783 cites W2132697533 @default.
• W2019156783 cites W2137757612 @default.
• W2019156783 cites W2143144750 @default.
• W2019156783 cites W2143954917 @default.
• W2019156783 cites W2144654172 @default.
• W2019156783 cites W2145632481 @default.
• W2019156783 cites W2146227799 @default.
• W2019156783 cites W2149146712 @default.
• W2019156783 cites W2151190145 @default.
• W2019156783 cites W2152094259 @default.
• W2019156783 cites W2152798629 @default.
• W2019156783 cites W2156975094 @default.
• W2019156783 cites W2157114317 @default.
• W2019156783 cites W2157527675 @default.
• W2019156783 cites W2157972885 @default.
• W2019156783 cites W2164834486 @default.
• W2019156783 cites W2169731574 @default.
• W2019156783 cites W2171146813 @default.

• next